Scahill L, Dalsgard S, Bradbury K (2013) The prevalence of Tourette syndrome and clinical characteristics in children. In: Martino D, Leckman JF (eds) Tourette sydrome. Oxford, New York, pp 121–136 Lin H, Yeh CB, Peterson BS, Scahill L, Grantz H, Findley DB et al (2002) Assessment of symptom exacerbations in a longitu- dinal study of children with Tourette’s syndrome or obsessive- compulsive disorder. J Am Acad Child Adolesc Psychiatry 41:1070–1077 Storch EA, Lack CW, Simons LE, Goodman WK, Murphy TK, Geffken GR (2007) A measure of functional impairment in youth with Tourette’s Syndrome. J Pediatr Psychol 32:950–959 4. Bitsko RH, Danielson M, King M, Visser SN, Scahill L, Perou R (2012) Health care needs of children with Tourette syndrome. J Child Neurol 28:1626–1636 Scahill L, Williams S, Schwab-Stone M, Applegate J, Leckman JF (2006) Disruptive behavior problems in a community sample of children with tic disorders. Adv Neurol 99:184–190 Kraft JT, Dalsgaard S, Obel C, Thomsen PH, Henriksen TB, Scahill L (2012) Prevalence and clinical correlates of tic disor- ders in a community sample of school-age children. Eur Child Adolesc Psychiatry 21:5–13 Scahill L, Sukhodolsky DG, Bearss K, Findley D, Hamrin V, Carroll DH et al (2006) Randomized trial of parent management training in children with tic disorders and disruptive behavior. J Child Neurol 21:650–656 8. Barkley RA (1997) Defiane children: a clinician’s manual for assessment and parent training. Guilford Press, New York 9. Sukhodolsky DG, Scahill L (2012) Cognitive-behavioral therapy for anger and aggression in children. Guilford Press, New York Insel TR (2009) Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry 66:128–133 United States Food and Drug Administration (August 2011) Strategic plan for regulatory science (2012–2016). Retrieved from http://www.fda.gov/downloads/ScienceResearch/Special Topics/RegulatoryScience/UCM268225.pdf Arnold LE, Wender PH, McCloskey K, Snyder SH (1972) Lev- oamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms. Arch Gen Psychiatry 27:816–822 Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM et al (2003) Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. J Am Acad Child Adolesc Psychi- atry 42:1443–1450 Weisz JR, Chorpita BF, Frye A, Ng MY, Lau N, Bearman SK et al (2011) Youth top problems: using idiographic, consumer- guided assessment to identify treatment needs and to track change during psychotherapy. J Consul Clin Psych 79:369–380 Weisz JR, Chorpita BF, Palinkas LA, Schoenwald SK, Miranda J, Bearman SK et al (2012) Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: a randomized effectiveness trial. Arch Gen Psychiatry 69:274–282 Kaufman J, Birmaher B, Brent D, Rao U (1997) Schedule for affective disorders and schizophrenia for school-age children- present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988 Feindler E, Ecton R (1986) Adolescent anger control: cognitive- behavioral techniques. Pergamon Press, New York 23. Gomez R, Burns GL, Walsh JA (2008) Parent ratings of the oppositional defiant disorder symptoms: item response theory